Carbon monoxide-releasing molecule-2 decreases fibrinolysis in vitro and in vivo in the rabbit

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 1, 2012, Pages 104-107

  Nielsen, Vance G ^a   Arkebauer, Matthew R ^a   Wasko, Kimberly A ^a   Malayaman, Saninuj N ^a   Vosseller, Keith ^b  

^a HAHNEMANN UNIVERSITY HOSPITAL   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

bleeding time; carbon monoxide releasing molecule; fibrinolysis; rabbit; thrombelastography

Indexed keywords

ANTIFIBRINOLYTIC AGENT; CARBON MONOXIDE RELEASING MOLECULE 2; COAGULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; BLEEDING TIME; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; DRUG EFFICACY; FIBRINOLYSIS; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; THROMBOELASTOGRAPHY;

ANIMALS; BLOOD COAGULATION; CARBON MONOXIDE; FIBRINOLYSIS; MALE; ORGANOMETALLIC COMPOUNDS; RABBITS;

EID: 84855194358     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32834ea012     Document Type: Article

References (17)

1. Nielsen VG, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in human plasma. Blood Coagul Fibrinolysis 2009; 20:377-380.
2. Nielsen VG, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 (CORM-2) decreases fibrinolysis in human plasma. Blood Coagul Fibrinolysis 2009; 20:448-455.
3. Nielsen VG, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 (CORM-2) increases the velocity of thrombus growth and strength in hemophilia A, hemophilia B and factor VII deficient plasmas. Blood Coagul Fibrinolysis 2010; 21:41-45.
4. Nielsen VG, Khan ES, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in subjects exposed to warfarin. Thromb Res 2010; 126:68-73.
5. Nielsen VG, Khan ES, Kirklin JK, George JF. Carbon monoxide releasing molecule enhances coagulation and diminishes fibrinolytic vulnerability in plasma exposed to heparin or argatroban. Anesth Analg 2010; 111:1347-1352.
6. Nielsen VG, Green P, Green M, Martin-Ross A, Khan ES, Kirklin JK,George JF. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in diluted plasma. J Trauma 2011; 70:939-947.
7. Pretorius E, Humphries P, Ekpo OE, Smit E, van der Merwe CF. Comparative ultrastructural analyses of mouse, rabbit, and human platelets and fibrin networks. Microsc Res Tech 2007; 70:823-827. (Pubitemid 47509781)
8. Nielsen VG, Khan ES, Huneke RB. Carbon monoxide releasing molecule-2 enhances coagulation in rat and rabbit plasma. Blood Coagul Fibrinolysis 2010; 21:298-299.
9. Malayaman SN, Nielsen VG, Cohen JB, Machovec KA, Bernhardt BE, Arkebauer MR. Carbon monoxide releasing molecule-2 enhances alpha-2- antiplasmin activity. Blood Coagul Fibrinolysis 2011; 22:345-348.
10. Nielsen VG, Cohen JB, Malayaman SN, Nowak M, Vosseller K. Fibrinogen is a heme-associated, carbon monoxide sensing molecule: A preliminary report. Blood Coagul Fibrinolysis 2011; 22:443-447.
11. Chlopicki S, Olszanecki R, Marcinkiewicz E, Lominicka M, Motterlini R. Carbon monoxide released by CORM-2 inhibits human platelets by a mechanism independent of soluble guanylate cyclase. Cardiovasc Res 2006; 71:393-401. (Pubitemid 43949260)
12. Soni H, Jain M, Mehta AA. Investigation into the mechanism(s) of antithrombotic effects of carbon monoxide releasing molecule-3 (CORM-3). Thromb Res 2011; 127:551-559.
13. Nielsen VG. Hemodilution modulates the time of onset and rate of fibrinolysis in human and rabbit plasma. J Heart Lung Transplant 2006; 25:1344-1352. (Pubitemid 44696322)
14. Stewart D, Kong M, Novokhatny V, Jesmok G, Marder VJ. Distinct dosedependent effects of plasmin and TPA on coagulation and hemorrhage. Blood 2003; 101:3002-3007. (Pubitemid 36857987)
15. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, Green CJ. Carbon monoxide-releasing molecules: Characterization of biochemical and vascular activities. Circ Res 2002; 90:e17-e24.
16. Clark JE, Naughton P, Shurey S, Green CJ, Johnson TR, Mann BE, et al. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 2003; 93:e2-e8.
17. Guo Y, Stein AB, Wu W, Tan W, Zhu X, Li Q, et al. Administration of a COreleasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 2004; 286:H1649-H1653. (Pubitemid 38525450)